Cargando…

Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients

BACKGROUND: High prevalence of Metabolic Syndrome (MS) was found in patients with schizophrenia and bipolar disorders. Insulin Resistance (IR) seems to mediate MS role in developing cardiometabolic consequences. AIMS: To investigate the prevalence of MS, and the role of MS components and IR surrogat...

Descripción completa

Detalles Bibliográficos
Autores principales: di Girolamo, Giulia, Bracco, Irene Francesca, Portigliatti Pomeri, Alberto, Puglisi, Soraya, Oliva, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253578/
https://www.ncbi.nlm.nih.gov/pubmed/35800021
http://dx.doi.org/10.3389/fpsyt.2022.891479
_version_ 1784740521282895872
author di Girolamo, Giulia
Bracco, Irene Francesca
Portigliatti Pomeri, Alberto
Puglisi, Soraya
Oliva, Francesco
author_facet di Girolamo, Giulia
Bracco, Irene Francesca
Portigliatti Pomeri, Alberto
Puglisi, Soraya
Oliva, Francesco
author_sort di Girolamo, Giulia
collection PubMed
description BACKGROUND: High prevalence of Metabolic Syndrome (MS) was found in patients with schizophrenia and bipolar disorders. Insulin Resistance (IR) seems to mediate MS role in developing cardiometabolic consequences. AIMS: To investigate the prevalence of MS, and the role of MS components and IR surrogate indexes in determining MS in adult ADHD outpatients. METHODS: In the present cross-sectional study, MS, defined according to the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III), and IR surrogate indexes were assessed on a consecutive sample of adult ADHD outpatients. Logistic regression analysis was performed to evaluate the effect of each ATP III component and IR surrogate index in determining MS. RESULTS: Seventeen out of 158 patients (10.8%, 95%CI = 0.064/0.167) fulfilled the ATP-III criteria for MS. A comprehensive comparison with prevalence in the reference population was hindered by the lack of patients over 60 in the study sample, however under this age no significant differences were found. Among MS components, blood triglycerides level (OR = 1.02, 95%CI=1.01/1.03, p = 0.001) was the main predictor for MS, followed by diastolic blood pressure (OR = 1.08, 95%CI=1.01/1.16, p = 0.024) and waist circumference (OR = 1.06, 95%CI=1.01/1.13, p = 0.029). Lipid Accumulation Product (LAP, OR = 1.0006, 95%CI=1.0003/1.0009, p < 0.001) outperformed Triglyceride-Waist Circumference (TG-WC, OR=1.03, 95%CI=1.01/1.04, p < 0.001) in predicting MS. CONCLUSIONS: More attention should be paid not only to MS but also to each ATP III component of MS and LAP in ADHD patients both at first assessment and during follow-up process.
format Online
Article
Text
id pubmed-9253578
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92535782022-07-06 Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients di Girolamo, Giulia Bracco, Irene Francesca Portigliatti Pomeri, Alberto Puglisi, Soraya Oliva, Francesco Front Psychiatry Psychiatry BACKGROUND: High prevalence of Metabolic Syndrome (MS) was found in patients with schizophrenia and bipolar disorders. Insulin Resistance (IR) seems to mediate MS role in developing cardiometabolic consequences. AIMS: To investigate the prevalence of MS, and the role of MS components and IR surrogate indexes in determining MS in adult ADHD outpatients. METHODS: In the present cross-sectional study, MS, defined according to the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III), and IR surrogate indexes were assessed on a consecutive sample of adult ADHD outpatients. Logistic regression analysis was performed to evaluate the effect of each ATP III component and IR surrogate index in determining MS. RESULTS: Seventeen out of 158 patients (10.8%, 95%CI = 0.064/0.167) fulfilled the ATP-III criteria for MS. A comprehensive comparison with prevalence in the reference population was hindered by the lack of patients over 60 in the study sample, however under this age no significant differences were found. Among MS components, blood triglycerides level (OR = 1.02, 95%CI=1.01/1.03, p = 0.001) was the main predictor for MS, followed by diastolic blood pressure (OR = 1.08, 95%CI=1.01/1.16, p = 0.024) and waist circumference (OR = 1.06, 95%CI=1.01/1.13, p = 0.029). Lipid Accumulation Product (LAP, OR = 1.0006, 95%CI=1.0003/1.0009, p < 0.001) outperformed Triglyceride-Waist Circumference (TG-WC, OR=1.03, 95%CI=1.01/1.04, p < 0.001) in predicting MS. CONCLUSIONS: More attention should be paid not only to MS but also to each ATP III component of MS and LAP in ADHD patients both at first assessment and during follow-up process. Frontiers Media S.A. 2022-06-21 /pmc/articles/PMC9253578/ /pubmed/35800021 http://dx.doi.org/10.3389/fpsyt.2022.891479 Text en Copyright © 2022 di Girolamo, Bracco, Portigliatti Pomeri, Puglisi and Oliva. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
di Girolamo, Giulia
Bracco, Irene Francesca
Portigliatti Pomeri, Alberto
Puglisi, Soraya
Oliva, Francesco
Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients
title Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients
title_full Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients
title_fullStr Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients
title_full_unstemmed Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients
title_short Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients
title_sort prevalence of metabolic syndrome and insulin resistance in a sample of adult adhd outpatients
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253578/
https://www.ncbi.nlm.nih.gov/pubmed/35800021
http://dx.doi.org/10.3389/fpsyt.2022.891479
work_keys_str_mv AT digirolamogiulia prevalenceofmetabolicsyndromeandinsulinresistanceinasampleofadultadhdoutpatients
AT braccoirenefrancesca prevalenceofmetabolicsyndromeandinsulinresistanceinasampleofadultadhdoutpatients
AT portigliattipomerialberto prevalenceofmetabolicsyndromeandinsulinresistanceinasampleofadultadhdoutpatients
AT puglisisoraya prevalenceofmetabolicsyndromeandinsulinresistanceinasampleofadultadhdoutpatients
AT olivafrancesco prevalenceofmetabolicsyndromeandinsulinresistanceinasampleofadultadhdoutpatients